Psychiatry for Practice, 2006, issue 1
Editorial
Obor adiktologie je odpovědí na požadavek
doc. PhDr. Michal Miovský Ph.D
Psychiatr. pro Praxi, 2006; 1: 3 
Review articles
CURRENT TRENDS IN THE BIOLOGICAL TREATMENT OF ALZHEIMER DISEASE
doc. MUDr. Roman Jirák CSc
Psychiatr. pro Praxi, 2006; 1: 8-11
We do not knot complex etiology of Alzheimer disease so far. That is why we are not able to treat such a sever dementia causally. Procedures that affect known pathogenetic chains are used. Evidence based management is only a treatment with acetylcholineesterase inhibitors and memantin. Some other procedures are reported, but their effect is not positively confirmed as with procedures mentioned above.
INTERESTING „UNKNOWN“ VALPROIC ACID
MUDr. Robert Matička
Psychiatr. pro Praxi, 2006; 1: 12-14
Valproic acid has been used like mood stabiliser for a long time, there is efficacy at mood stabilizing and treatment of BAP. However there is unclear the distinct mechanism of efficacy at BAP treatment. A lot of effects of valproic acid are known on subcellular degree, even with the influence on CNS plasticity.
SECOND GENERATION ANTIPSYCHOTICS IN RELAPSE PREVENTION OF SCHIZOPHRENIA - THE RECENT FINDINGS FROM SELECTED DOUBLE-BLIND, RANDOMIZED TRIALS
Mudr. Ján Pečeňák CSc
Psychiatr. pro Praxi, 2006; 1: 16-19
Schizophrenia is a disease with a prolonged course and frequently a life time treatment. Second-generation antipsychotics should be undoubtedly advantageous, because of their complex effect and better tolerance. However many factors influencing the treatment complicate the evaluation the effect of individual medications or their classes. A natural unfavorable course of the disease is one of them as well as low compliance with treatment in patients with schizophrenia. These factors are emphasized in the review and results of recently published studies are discussed.
THE TREATMENT OF CHRONIC INSOMNIA - IS AN AGE THE CRUCIAL FACTOR?
MUDr. Claudia Borzová, MUDr. Petr Kozelek, MUDr. Vladimír Kmoch
Psychiatr. pro Praxi, 2006; 1: 20-22
Insomnia is the most common sleep disorder, which is encountered at the specialised clinics for sleep and vigil disorders. It can be encountered at any age and affects both sexes with mild female predominance. This article is dedicated to the treatment of chronic insomnia and alerts on the differences with regards to patient’s age. Both methods, pharmacotherapy and psychotherapy (especially cognitive behavioural psychotherapy – CBP), can be used in insomniacs of any age only with certain exceptions. Long-term use of benzodiazepine and non-benzodiazepine medications is risky for insomniacs with organic psychosyndrome and impaired cognitive...
ANTIDEPRESSANTS IN THE TREATMENT OF FEMALE SEXUAL DYSFUNCTION
prof. MUDr. Alexandra Žourková CSc
Psychiatr. pro Praxi, 2006; 1: 23-25
The author describes studies of therapeutic efficaccy of antidepressants in the treatment of female sexual dysfunction. Antidepressants stimulating sexual activity (moclobemide, bupropion, trazodone) demonstrate good results in the therapy of decreased libido and female arousal disorder.
ALCOHOL WITHDRAWAL SYNDROME THERAPY
MUDr. Zdeněk Faldyna, MUDr. Iveta Zedková
Psychiatr. pro Praxi, 2006; 1: 27-28
Alcohol addiction is a serious social and medical problem. Besides the antialcohol therapy, in a setting of psychiatric practice, we also focus on the management of the withdrawal syndrome connected to alcohol addiction. Withdrawal syndrome is very often one the first complications, what brings patient to psychiatric treatment. It is one of the most common indications for a psychiatric consult and can significantly complicate the course of somatic disorder treatment. Methods for management of withdrawal syndromes are not unified and it is possible to say, that there is a trend to influence causally the impaired balance between excitation and inhibitory...
THE TREATMENT OF PSYCHOTIC DEPRESSION - ACUTE AND CONTINUATION DRUG TREATMENT
MUDr. Martin Bareš, MUDr. Miloslav Kopeček Ph.D
Psychiatr. pro Praxi, 2006; 1: 29-33
The psychotic depression is relatively common type of depressive disorder. It is different from non – psychotic form of unipolar depression in certain characteristics (eg. response to treatment, risk of suicide, course and prognosis of illness etc.). Authors review efficacy of various pharmacological treatment of psychotic depression (tricyclic antidepressants, selective serotonin reuptake inhibitors, antipsychotics). The most effective pharmacological acute treatment of psychotic depression is according to results of clinical trials combination of antidepressant and antipsychotic. The use of atypical antipsychotics with selective serotonin reuptake...
PRESENT AND FUTURE OF ADHD PSYCHOPHARMACOLOGY IN CZECH REPUBLIC AND IN ABROAD
doc. MUDr. Ivo Paclt CSc
Psychiatr. pro Praxi, 2006; 1: 34-37
Review characterized international psychopharmacological praxis in therapy of ADHD. Paper compared present and future at ADHD psychopharmacology in Czech republic. Author takes down all drugs what are uses full in various types of ADHD and co morbid conduct disorders.
Case report
Monitorovací systém LEX-SYS
MUDr. Vladimír Kmoch
Psychiatr. pro Praxi, 2006; 1: 38
Comments
Kritika závěrů studie CATIE aneb jak složité je zkoumat léčbu antipsychotiky
MUDr. Martin Anders Ph.D
Psychiatr. pro Praxi, 2006; 1: 50-52
Psychopharmacology
Jaká je budoucnost quetiapinu?
MUDr. Jiří Masopust, MUDr. Ing. Aleš Urban, MUDr. Martin Vališ
Psychiatr. pro Praxi, 2006; 1: 43-49
Outpatient psychiatry
Venlafaxin s prodlouženým uvolňováním v ambulantní praxi
MUDr. Luboš Janů Ph.D
Psychiatr. pro Praxi, 2006; 1: 39-42
Information and commentaries
VII. český a II. česko-slovenský sjezd o spánku
MUDr. Miroslav Moráň
Psychiatr. pro Praxi, 2006; 1: 53
Ze zahraniční literatury
MUDr. Tomáš Kašpárek Ph.D
Psychiatr. pro Praxi, 2006; 1: 54